News

Press Release
RepliCel Receives Issue Notification from the United States Patent and Trademark Office Protecting Methods of Preparing Dermal Sheath Cup Cells for its Hair Regeneration Technology
VANCOUVER, BC – April 18, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel Announces Closing of Private Placement
VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel to Present at the 11th Annual BioPartnering North America Conference
Vancouver Convention Centre, Vancouver, BC, February 24-26th, 2013 VANCOUVER, BC – February 19th 2013 –...
Press Release
RepliCel Announces Re-Pricing of Warrants
VANCOUVER, BC – February 8, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel to Meet with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Process
Phase II Dose Ranging Trial Planned for 2013 VANCOUVER, BC – February 4, 2013 –...
Press Release
RepliCel Completes First Pre-Filing Review with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Pro
Phase II Dose Ranging Trial on its Hair Cell Replication Technology Expected to Commence Mid-2013...
Press Release
RepliCel’s Common Shares Listed on CNSX
VANCOUVER, BC – October 1, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Events
RepliCel’s Chief Medical Officer to Present at 21st European Academy of Dermatology & Venereology Congress
VANCOUVER, BC – September, 26, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Events
RepliCel to Present at Rodman and Renshaw Global Investment Conference
VANCOUVER, BC – September 10, 2012 – RepliCel Life Sciences Inc.’s (the “Company” or “RepliCel”)...
As Seen In
Chief Scientist Dr. Kevin McElwee Interviewed In Barcelona Article at Eldiariomontanes.es
 (English Translation)Injected hair stem cells are emerging as the most effective therapy against baldness
 EFE...
As Seen In
Chief Scientist Dr. Kevin McElwee Interviewed In Barcelona Article at Hazteoir.org
(English Translation) HAZTEOIR.ORG 
The website of the active citizen June 22, 2012 The patient’s own...
Press Release
RepliCels Chief Scientific Officer Updates European Hair Research Society on RepliCels TS001-2009 First-in-man Clinical Trial
VANCOUVER, BC – June 26, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
Further Analysis Reveals Double Digit Hair Growth in RepliCels First-in-man Clinical Trial
Company Takes Next Steps for Phase IIb Dosing Trial VANCOUVER, BC – May 17, 2012...
Press Release
RepliCel Releases Positive Results from the Interim Analysis of Data from its First-in-man TS001-2009 Clinical Trial
VANCOUVER, BC – May 2, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
As Seen In
Ask Men features an interview with RepliCel Life Sciences CEO David Hall
 AskMen.comMen And Balding By Jeremy Berger, February 6, 2012The plague that has dogged us for...
As Seen In
September 11th Episode of The Bald Truth featuring RepliCel Life Sciences
To watch the September 11th episode of The Bald Truth, click here: http://www.youtube.com/watch?v=N8yO96ANRYc ...

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.